These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18485615)

  • 1. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
    McBride SM; Daganzo SM; Banerjee A; Gupta N; Lamborn KR; Prados MD; Berger MS; Wara WM; Haas-Kogan DA
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1319-23. PubMed ID: 18485615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
    Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S; Krieger MD; Bowen I; McComb JG
    J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.
    Pizer BL; Weston CL; Robinson KJ; Ellison DW; Ironside J; Saran F; Lashford LS; Tait D; Lucraft H; Walker DA; Bailey CC; Taylor RE
    Eur J Cancer; 2006 May; 42(8):1120-8. PubMed ID: 16632346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor.
    Paulino AC; Cha DT; Barker JL; Lo S; Manera RB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1171-6. PubMed ID: 15001261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study.
    Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Yao MS; Zeltzer PM
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):204-13. PubMed ID: 15337557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
    Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boost radiosurgery as a strategy after failure of initial management of pediatric primitive neuroectodermal tumors.
    Flannery T; Kano H; Martin JJ; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
    J Neurosurg Pediatr; 2009 Mar; 3(3):205-10. PubMed ID: 19338466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiotherapy and/or chemotherapy in children with primitive neuroectodermal tumor (PNET) of the pineal region].
    Dunst J
    Strahlenther Onkol; 1996 Feb; 172(2):108-9. PubMed ID: 8669042
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials.
    Timmermann B; Kortmann RD; Kühl J; Rutkowski S; Meisner C; Pietsch T; Deinlein F; Urban C; Warmuth-Metz M; Bamberg M
    J Clin Oncol; 2006 Apr; 24(10):1554-60. PubMed ID: 16575007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
    Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Zeltzer PM
    Pediatr Blood Cancer; 2005 Oct; 45(5):676-82. PubMed ID: 16007595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pineal and nonpineal supratentorial primitive neuroectodermal tumors.
    Jakacki RI
    Childs Nerv Syst; 1999 Oct; 15(10):586-91. PubMed ID: 10550590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy.
    Jabbari S; Andolino D; Weinberg V; Missett BT; Law J; Wara WM; O'Donnell RJ; Matthay KK; DuBois SG; Goldsby R; Haas-Kogan DA
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):177-82. PubMed ID: 19410386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.